IP Library › Granted Patent US 10,080,805
Granted Patent B2
US 10,080,805 · App. 14/380,273 · Granted Sep 25, 2018

Cholecystokinin B receptor targeting for imaging and therapy

Inventors: Philip S. Low (West Lafayette, IN); Charity Wayua (West Lafayette, IN)
Assignee: Purdue Research Foundation
A61K47/48061A61K31/4409A61K31/475A61K38/06A61K38/07A61K38/08A61K49/0052A61K51/02A61K51/047A61K51/0468C07D243/12C07D405/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,080,805
App. No.
14/380,273
Granted
Sep 25, 2018
Kind
B2
Abstract

Conjugates are described herein where CCK2R targeting ligands are attached to an active moiety, such as therapeutic agent or an imaging agent, through a linker. The conjugates can be used in the detection, diagnosis, imaging and treatment of cancer.

Claims (2)

1. A conjugate of formula

or a pharmaceutically acceptable salt thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2014
From: LOW, PHILIP S.; WAYUA, CHARITY
To: PURDUE RESEARCH FOUNDATION
Reel/Frame 034031/0685 →
Continuity (2)
Provisional Application 61602831 · Feb 24, 2012
Related Publication 20150050212A1 · Feb 19, 2015
Cited By (1)
US 12,485,179